Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients
FMT has gained enormous momentum in the treatment of acute inflammatory and infectious diseases. Despite an encouraging safety profile, FMT has been met with caution in the oncological setting due to perceived infectious risks in immunocompromised patients. Theoretical risks aside, the application o...
Main Authors: | H.R. Wardill, K.R. Secombe, R.V. Bryant, M.D. Hazenberg, S.P. Costello |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396419302154 |
Similar Items
-
Fecal microbiota transplantation for refractory diarrhea in immunocompromised diseases: a pediatric case report
by: Shuwen Zhong, et al.
Published: (2019-08-01) -
Investigating causality with fecal microbiota transplantation in rodents: applications, recommendations and pitfalls
by: Cassandra E. Gheorghe, et al.
Published: (2021-01-01) -
Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation
by: Laura Alagna, et al.
Published: (2020-08-01) -
A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients
by: Oluwaseun Shogbesan, et al.
Published: (2018-01-01) -
Long-term taxonomic and functional divergence from donor bacterial strains following fecal microbiota transplantation in immunocompromised patients.
by: Eli L Moss, et al.
Published: (2017-01-01)